Status:
RECRUITING
STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies
Lead Sponsor:
IRCCS Fondazione Stella Maris
Collaborating Sponsors:
IRCCS Eugenio Medea
Università degli studi di Messina
Conditions:
Hereditary Spastic Paraplegia
Eligibility:
All Genders
Brief Summary
Our goal is to create a solid and harmonious disease registry of patient affected by hereditary spastic paraplegia (HSP) that facilitates the collection and management of patients' data over time enco...
Detailed Description
The registry will involve five recruiting clinical centres (IRCCS Fondazione Stella Maris in Pisa, IRCCS Eugenio Medea in Conegliano, IRCCS Policlinico Gemelli in Rome, IRCCS Istituto di Scienze Neuro...
Eligibility Criteria
Inclusion
- clinical diagnosis of pure or complex HSP/spastic ataxia, even in the absence of a known genetic diagnosis
- participants/parents/legal guardians will have to give informed consent for enrollment in the registry and privacy data management
Exclusion
- subjects affected by secondary forms of HSP
- presenting comorbidities that affect the general clinical picture according to clinical judgment
- lack of informed consent
Key Trial Info
Start Date :
January 24 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06572046
Start Date
January 24 2024
End Date
December 31 2029
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Fondazione Stella Maris
Pisa, Italy, 56128